Skip to main content
. 2021 Oct;9(20):1523. doi: 10.21037/atm-21-4470

Table 3. Univariate and multivariate Cox regression analysis of the clinicopathological features and potential models in this study.

Variables Patients (n=504), n (%) Univariate analysis Multivariate analysis
HR (95% CI) P value HR (95% CI) P value
Age (years) 1.25 (0.881–1.791) 0.207
   60 387 (76.79)
   ≤60 108 (21.43)
   Missing# 9 (1.79)
Gender 1.197 (0.871–1.644) 0.266
   Male 373 (74.01)
   Female 131 (25.99)
TNM stage 1.560 (1.135–2.143) 0.006** 1.237 (0.780–1.964) 0.366
   Stage I/II 408 (80.95)
   Stage III/IV 92 (18.25)
   Missing# 4 (0.79)
M status 3.065 (1.253–7.500) 0.014* 2.316 (0.886–6.054) 0.086
   M0 414 (82.14)
   M1 7 (1.39)
   Missing# 83 (16.47)
N status 1.151 (0.872–1.520) 0.318
   N0 320 (63.49)
   N1–N3 178 (35.32)
   Missing# 6 (1.19)
T status 1.648 (1.196–2.270) 0.0022** 1.369 (0.858–2.182) 0.1872
   T1–T2 409 (81.15)
   T3–T4 95 (18.85)
Smoking grade 1.540 (1.161–2.042) 0.0027** 1.699 (1.240–2.3309) 0.00098**
   Grade 1–2 152 (30.16)
   Grade 3–5 340 (67.46)
   Missing# 12 (2.38)
FTO (eraser) 1.175 (0.986–1.400) 0.069
   Low 252 (50.00)
   High 252 (50.00)
FTO (CNV) 0.783 (0.464–1.321) 0.359
   Loss 15 (50.00)
   Gain 18 (50.00)
METTL3 (writer) 0.932 (0.769–1.130) 0.477
   Low 252 (50.00)
   High 252 (50.00)
METTL3 (CNV) 0.917 (0.663–1.268) 0.601
   Loss 43 (50.00)
   Gain 44 (50.00)
KIAA1429 (writers) 1.177 (0.970–1.426) 0.098
   Low 249 (50.30)
   High 246 (49.70)
Two-gene model (FTO + METTL) 1.44 (1.095–1.891) 0.0089** 1.634 (1.038–2.572) 0.0014**
   Low 246 (48.81)
   High 249 (49.40)

#, ambiguous variables (missing) were excluded. *, P<0.05; **, P<0.01. HR, hazard ratio; CI, confidence interval; TNM, tumor, node and metastasis; CNV, copy number variant.